Postmarketing safety study based on Pregnancy Registry on women exposed to Palforzia during pregnancy and on infants exposed to Palforzia in utero

18/06/2021
13/02/2026
EU PAS number:
EUPAS41546
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information